National Lung Cancer Screening Program: Additional findings detected during lung cancer screening

Date
12 Aug 2025
06:30 PM - 08:00 PM

Cost
Free

Available to
Practice Nurses
Practice Managers
General Practitioners

Continuing Professional Development

1.5 RACGP CPD hours - Educational Activities

Australia has launched a new National Lung Cancer Screening Program in July 2025. This is the third of a series of educational webinars planned in preparation for the new program.

This session will cover additional findings, not related to lung cancer, which are detected during lung cancer screening. This session will focus on potentially clinically significant respiratory and cardiovascular additional findings. 

This session will also provide information about a new service at the Royal Melbourne Hospital to support primary care providers with the start of the National Lung Cancer Screening Program.

At the end of the session, audience members will be familiar with the different types of additional findings, how to assess potentially significant respiratory and cardiovascular additional findings, and local resources available. 

Speakers

Dr Asha Bonney is a Respiratory and Sleep Physician at the Royal Melbourne Hospital (RMH). Her other roles include Senior Research Fellow at the University of Melbourne, Respiratory and Sleep Physician at Eastern Health, and Member of the Thoracic Society of Australia and New Zealand Lung Cancer Working Party. She recently completed a PhD in the field of lung cancer screening and is the clinical lead of the Lung Nodule Clinic at RMH and lead of the Lung Nodule and Screening Program at RMH.

A/Prof Renee Manser is a Respiratory and Sleep Physician at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre. She has a PhD in lung cancer screening and is an honorary Associate Professor in the Department of Medicine, University of Melbourne. A/Prof Renee Manser has extensive clinical experience in lung cancer diagnosis and management and is a Principal Investigator on the International Lung Screen Trial. A/Prof Manser is co-editor for the Cochrane Lung Cancer Review Group and a regular scientific reviewer for the Melbourne Health Human Research Ethics Committee.

Dr Alistair Miller is a respiratory and sleep physician at the Royal Melbourne Hospital and Peter MacCallum Cancer Centre.

Learning outcomes:

By the end of this activity, participants will be able to:

  • Differentiate between different types of additional findings 
  • Identify and evaluate coronary artery calcification
  • Identify and evaluate emphysema and interstitial lung abnormalities
  • Explain the new lung cancer screening pumonary nodule managent pathways and HealthPathways